NICE guidance increases treatment options for patients with severe ankylosing spondylitis

The National Institute for Health and Care Excellence (NICE) has published guidance recommending infliximab for use within its marketing authorisation as an option for treating severe active…

Source link


Would you like to get the test?

This entry was posted in Uncategorized. Bookmark the permalink.